TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: acknowledgment of difficulties
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: recovery support
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in medication storage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in firearm storage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BrACs (Blood Alcohol Concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of hangover symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive testing scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Composite primary endpoint by Day 14
Endpoint domain: Mortality/survival
Primary endpoint: Presence of follicles in the lower tarsal conjunctiva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular signs
Primary endpoint: Conjunctival injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular signs
Primary endpoint: post-operative astigmatic vector power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients reaching target HbA1c (<7.5%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of DKA and severe hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Knee extensors strength at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Polypoidal lesion closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of referred pain area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Access to assistive technology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thread the Ring 1 learning curves score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in daily dosage of opioid drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom reporting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Barriers to help-seeking
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: confirmed response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: %TIR (time in range 70-180 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute urinary retention requiring repeat catheterisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: post-anxiolytic-mYPAS-scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PSAS-Score 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAS-Score 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic distension of the jejunum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Diagnostic distension of the terminal ileum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Diagnostic distension of the colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: HBV RNA response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: L1-L4 BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voice-related disability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of decline in MMSE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum pain-free mouth opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraocular pressure (IOP) at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Number of glaucoma medications at 5 years
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement in treadmill ergometry results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of female authorship
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Early bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in cough scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shorter duration of cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TDAS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Physical function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: composite CV events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: peak MTCF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MTCF impulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PWA burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: WMFT improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grasp strength improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leuven Postprandial Distress Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: axillary failure rate
Endpoint domain: Mortality/survival
Primary endpoint: SARS‐CoV‐2 infection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: OSCE scores at hemoptysis station
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OSCE scores at syncope station
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Student experience with OSCE
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: distant metastasis probability
Endpoint domain: Mortality/survival
Primary endpoint: Gum recession
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: paretic knee flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Walking distance (Six-Minute Walk Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median daily iodine intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of participants with iodine intake above WHO cutoff
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average iodine concentration in household salt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of hospitalizations per patient per year
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of hospitalization days related to HPN per patient per year
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: SVA (Sagittal Vertical Axis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score (Visual Analog Scale)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: provider productivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wait times
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: rate of readmissions for biliary events
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: emotional and behavioural symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid-free recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cholesterol decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nutritional scores on the MNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functionality score in the functional domain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Odds ratio of fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of eBMD levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: non-resting time use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: income-generating time use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: households’ asset ownership and living standards
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: hospital mortality prediction
Endpoint domain: Mortality/survival
Primary endpoint: Prevention of thromboembolism
Endpoint domain: Mortality/survival
Primary endpoint: Tachycardia frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neonatal cerebral regional saturations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTAa reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical instantaneous loading rate reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in GERD-HRQL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of patients off-PPI at 12 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: median free BTK
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stronger habits
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Higher levels of collaborative planning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Higher levels of collaborative social control
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Higher adherence to supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Micronutrient concentrations (Hb, vitamin D, iron, folate, calcium)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nocturia episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Average inter-void interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Urinary urgency episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: endoscopic improvement (≥50% reduction in SES‐CD from baseline)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sCOMPCHANGE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quadriceps muscle atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: incidence of grade 2 or higher gastrointestinal toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: incidence of all grade 3 or 4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: pulmonary infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Number of views
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Engagements
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Altmetric scores
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: FDI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone metastasis
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of successful responders with a reduction of at least 50% of VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean OKS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parents' correct use of RAAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of NBI during flexible endoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of T staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: improvement in fatigue symptoms
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: 30-day HF rehospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Fewer visits cancelled by parents
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Higher caseworker receptivity to contact
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Higher parent satisfaction with contact
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cmax,ss of risperidone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmin,ss of the active moiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-tau,ss of the active moiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General mental health improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: OSFS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic midline catheter-related thrombosis (CRT)
Endpoint domain: Adverse events/effects
Primary endpoint: Premature catheter failure
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in esotropia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in face turn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in abduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decline in the use of avoidance coping
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Partial Mayo score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flare-up incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life (satisfaction with health)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Secondary task performance (error rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year cumulative mortality
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in HDR score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in MHIS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced burnout
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduced alcohol use
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Hypertrophic scarring incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: POSAS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Perception of accuracy and reliability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Finger mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month disability worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive ability for GQB development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resistance to meropenem
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Susceptibility to colistin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Association with primary bacteraemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in OHRQoL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction of depressivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in CPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thrombolysis In Myocardial Infarction flow grade 0/1 pre-PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: First-attempt success rate of radial artery cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: total aberration reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate indication for PPI prescription
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adequate choice of PPI molecule
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adequate dosing of PPI
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: sRANKL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of sustained and exclusive breastfeeding through 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction efficacy of radiomics signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical response to MBSR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to treatment in ADHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positive-predictive value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complexity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of median frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Force error rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased gambling involvement
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: Satisfaction at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of apnea episodes (≥2 times/day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of intraventricular hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Mean PGE‐2 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of misoprostol use
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Side-effect thresholds
Endpoint domain: Adverse events/effects
Primary endpoint: DAS28-hsCRP ≤ 3.2 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FACIT-F
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean bodyweight reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PD (Periodontal Disease) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOP (Bleeding on Probing) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDF (Laser Doppler Flowmetry) values decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: macular vascular density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of pediatric resuscitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective workload
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Incidence of mild-to-moderate Covid-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colonization by Lactobacilli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colonization by Bifidobacterium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Earlier colonization time for Lactobacillus and Bifidobacterium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regular consumption of fruit and vegetables (F + V)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate consumption of fruit and vegetables (F + V)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized rate of moderate-to-severe COPD exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Trough FEV1 benefit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean levels of right CIMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Absolute rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average number of medication access services provided
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Volume of suprapatellar bursa effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion with low birth weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes